This protocol is judged by an institutional overview board, an independent group that evaluations any clinical trials involving people. If a research consists of a Routine I drug, when the board approves the protocol as ethical, the scientists really have to apply for an investigational new drug (IND) amount with the FDA.Consequently, drugs tend to